GSK to Gain Chronic Cough Drug With $2B Buyout of Bellus Health
Acquiring Bellus Health gives GSK a drug for recurrent chronic cough that could offer a better side effect profile compared to a Merck drug that addresses the same target. Bayer was also pursuing the target, but stopped work on its drug candidate last year.
Luke Miel Bellus Health Quebec Based Bellus Commercial Officer Luke Miel Weight Loss Medical Devices
Source: medcitynews.com